CoChat

Use of 3D-CT-derived psoas major muscle volume in defining sarcopenia in colorectal cancer

Takahashi, Makoto, Sakamoto, Kazuhiro, Kogure, Yosuke, Nojiri, Shuko, Tsuchiya, Yuki, Honjo, Kumpei, Kawai, Masaya, Ishiyama, Shun, Sugimoto, Kiichi, Nagakari, Kunihiko, Tomiki, Yuichi · 2024 · BMC Cancer

Published version of a preprint

Cited by 9

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: Sarcopenia is characterized by reduced skeletal muscle volume and is a condition that is prevalent among elderly patients and associated with poor prognosis as a comorbidity in malignancies. Given the aging population over 80 years old in Japan, an understanding of malignancies, including colorectal cancer (CRC), complicated by sarcopenia is increasingly important. Therefore, the focus of this study is on a novel and practical diagnostic approach of assessment of psoas major muscle volume (PV) using 3-dimensional computed tomography (3D-CT) in diagnosis of sarcopenia in patients with CRC. Methods: The subjects were 150 patients aged ≥ 80 years with CRC who underwent primary tumor resection at Juntendo University Hospital between 2004 and 2017. 3D-CT measurement of PV and conventional CT measurement of the psoas major muscle cross-sectional area (PA) were used to identify sarcopenia (group S) and non-sarcopenia (group nS) cases. Clinicopathological characteristics, operative results, postoperative complications, and prognosis were compared between these groups. Results: The S:nS ratios were 15:135 for the PV method and 52:98 for the PA method. There was a strong positive correlation ( r = 0.66, p < 0.01) between PVI (psoas major muscle volume index) and PAI (psoas major muscle cross-sectional area index), which were calculated by dividing PV or PA by the square of height. Surgical results and postoperative complications did not differ significantly in the S and nS groups defined using each method. Overall survival was worse in group S compared to group nS identified by PV ( p < 0.01), but not significantly different in groups S and nS identified by PA ( p = 0.77). A Cox proportional hazards model for OS identified group S by PV as an independent predictor of a poor prognosis ( p < 0.05), whereas group S by PA was not a predictor of prognosis ( p = 0.60). Conclusions: The PV method for identifying sarcopenia in elderly patients with CRC is more practical and sensitive for prediction of a poor prognosis compared to the conventional method.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-024-12524-y

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 35

  1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S–S991. · DOI · Paper page
  2. Sun Q, Jiang X, Qin R, et al. Sarcopenia among older patients with cancer: A scoping review of the literature. J Geriatr Oncol. 2022;13:924–34. · DOI
  3. Surov A, Strobel A, Borggrefe J, Wienke A. Low skeletal muscle mass predicts treatment response in oncology: a meta-analysis. Eur Radiol. 2023;33(9):6426–37. · DOI
  4. Surov A, Pech M, Gessner D, Mikusko M, Fischer T, Alter M, Wienke A. Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis Clin Nutr. 2021;40(10):5298–310.
  5. Trejo-Avila M, Bozada-Gutiérrez K, Valenzuela-Salazar C, Herrera-Esquivel J, Moreno-Portillo M. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021;36(6):1077–96. · DOI · Paper page
  6. Meyer HJ, Strobel A, Wienke A, Surov A. Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal Cancer: A Systematic Review and Meta-Analysis. Clin Colorectal Cancer. 2022;21(3):e213–25. · DOI
  7. Vergara-Fernandez O, Trejo-Avila M, Salgado-Nesme N. Sarcopenia in patients with colorectal cancer: A comprehensive review. World J Clin Cases. 2020;8:1188–202. · DOI
  8. Hirayama K. The measurement of the psoas major muscle volume by 3 dimensional-CT for assessment of nutritional state. J Jpn Soc Parenteral Enteral Nutr. 2017;32:871–7.
  9. Brierley J, Gospodarowicz M, Wittekind C. UICC TNM classification of malignant tumours. 8th ed. Chichester: Wiley; 2017.
  10. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13. · DOI · Paper page
  11. Takahashi M, Niitsu H, Sakamoto K, et al.: Japan Society of Laparoscopic Colorectal Surgery. Survival benefit of lymph node dissection in surgery for colon cancer in elderly patients: A multicenter propensity score-matched study in Japan. Asian J Endosc Surg. 2018;11:346–54. · doi:10.1111/ases.12474
  12. Merchant RA, Seetharaman S, Au L, et al. Relationship of fat mass index and fat free mass index with body mass index and association with function, cognition and sarcopenia in pre-frail older adults. Front Endocrinol (Lausanne). 2021;12:765415. · DOI
  13. Williams GR, Rier HN, McDonald A, et al. Sarcopenia and aging in cancer. J Geriatr Oncol. 2019;10:374–7. · DOI
  14. Xia L, Zhao R, Wan Q, et al. Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies. Cancer Med. 2020;9:7964–78. · DOI · Paper page
  15. Nipp RD, Fuchs G, El-Jawahri A, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist. 2018;23:97–104. · DOI · Paper page
  16. Takiguchi K, Furuya S, Sudo M, et al. Prognostic effect of sarcopenia in colorectal cancer recurrence. Nutrition. 2021;91–92:111362. · DOI
  17. Tagliafico AS, Bignotti B, Torri L, et al. Sarcopenia: how to measure, when and why. Radiol Med. 2022;127:228–37. · DOI · Paper page
  18. Di Vincenzo O, Marra M, Di Gregorio A, et al. Bioelectrical impedance analysis (BIA)-derived phase angle in sarcopenia: A systematic review. Clin Nutr. 2021;40:3052–61. · DOI · Paper page
  19. Pickhardt PJ, Perez AA, Garrett JW, et al. Fully automated deep learning tool for sarcopenia assessment on ct: l1 versus l3 vertebral level muscle measurements for opportunistic prediction of adverse clinical outcomes. AJR Am J Roentgenol. 2022;218:124–31. · DOI
  20. Horie K, Matsuda T, Yamashita K, et al. Sarcopenia assessed by skeletal muscle mass volume is a prognostic factor for oncological outcomes of rectal cancer patients undergoing neoadjuvant chemoradiotherapy followed by surgery. Eur J Surg Oncol. 2022;48:850–6. · DOI
  21. Yamada Y, Shimada Y, Makino Y, et al. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer. J Cancer Res Clin Oncol. 2023;149:3277–85. · DOI
  22. Manabe T, Ogawa C, Takuma K, et al. Usefulness of the measurement of psoas muscle volume for sarcopenia diagnosis in patients with liver disease. Diagnostics (Basel). 2023;13:1245. · DOI
  23. So SP, Lee BS, Kim JW. Psoas muscle volume as an opportunistic diagnostic tool to assess sarcopenia in patients with hip fractures: A retrospective cohort study. J Pers Med. 2021;11:1338. · DOI
  24. Womer AL, Brady JT, Kalisz K, et al. Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection? Am J Surg. 2018;215:503–6. · DOI
  25. Kim SE, Paik HY, Yoon H, et al. Sex- and gender-specific disparities in colorectal cancer risk. World J Gastroenterol. 2015;21:5167–75. · DOI · Paper page
  26. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–65. · DOI · Paper page
  27. Conlon KC, Lugli E, Welles HC, et al. Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer. J Clin Oncol. 2015;33:74–82. · DOI · Paper page
  28. Daitoku N, Miyamoto Y, Hiyoshi Y, et al. Preoperative skeletal muscle status is associated with tumor-infiltrating lymphocytes and prognosis in patients with colorectal cancer. Ann Gastroenterol Surg. 2022;6:658–66. · DOI
  29. Kim M, Lee SM, Son IT, Park T, Oh BY. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer. Korean J Radiol. 2023;24(9):849–59. · DOI
  30. Dohzono S, Sasaoka R, Takamatsu K, Hoshino M, Nakamura H. Prognostic value of paravertebral muscle density in patients with spinal metastases from gastrointestinal cancer. Support Care Cancer. 2019;27(4):1207–13. · DOI
  31. Yao H, Dohzono S, Sasaoka R, Takamatsu K, Nakamura H. Prognostic value of psoas major muscle density in patients with breast cancer metastases to bone: a retrospective single-center cohort study. Jpn J Clin Oncol. 2022;52(1):8–13. · DOI
  32. Cuijpers ACM, Bongers BC, Heldens AFJM, Bours MJL, van Meeteren NLU, Stassen LPS, Lubbers T. Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery. J Surg Oncol. 2022;125(6):1013–23. · DOI
  33. van der Zanden V, van Soolingen NJ, Viddeleer AR, Trum JW, Amant F, Mourits MJE, Portielje JEA, van den Bos F, de Kroon CD, Kagie MJ, Oei SA, Baalbergen A, van Haaften-de Jong ALD, Houtsma D, van Munster BC, Souwer ETD. Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer. Gynecol Oncol. 2021;162(2):360–7. · DOI
  34. Kurokawa Y. How can sarcopenia be prevented after gastrointestinal surgery? Ann Gastroenterol Surg. 2022;6:604–5. · doi:10.1002/ags3.12617
  35. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21:300–7.e2. · DOI · Paper page

Metadata

Authors
Takahashi, M., Sakamoto, K., Kogure, Y., Nojiri, S., Tsuchiya, Y., Honjo, K., Kawai, M., Ishiyama, S., Sugimoto, K., Nagakari, K., & Tomiki, Y.
Venue
BMC Cancer
Published
2024-06-18
Volume
24
Issue
1
ISSN
1471-2407
Cited by
9
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of 3D-CT-derived psoas major muscle volume in defining sarcopenia in colorectal cancer. https://app.cochat.ai/papers/10.1186/s12885-024-12524-y
The paper
Takahashi, M., Sakamoto, K., Kogure, Y., Nojiri, S., Tsuchiya, Y., Honjo, K., Kawai, M., Ishiyama, S., Sugimoto, K., Nagakari, K., & Tomiki, Y. (2024). Use of 3D-CT-derived psoas major muscle volume in defining sarcopenia in colorectal cancer. BMC Cancer. https://doi.org/10.1186/s12885-024-12524-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.